Kumujan B suppresses TNF-α-induced inflammatory response and alleviates experimental colitis in mice

• Váldodahkkit: Xunwei Li (Dahkki), Qianqian Di (Dahkki), Xiaoli Li (Dahkki), Xibao Zhao (Dahkki), Han Wu (Dahkki), Yue Xiao (Dahkki), Haimei Tang (Dahkki), Xucan Huang (Dahkki), Jin Chen (Dahkki), Shaoying Chen (Dahkki), Yuli Gao (Dahkki), Junbo Gao (Dahkki), Weilie Xiao (Dahkki), Weilin Chen (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Treatments of inflammatory bowel disease (IBD) are diverse, but their efficacy is limited, and it is therefore urgent to find better therapies. Controlling mucosal inflammation is a must in IBD drug treatment. The occurrence of anti-tumor necrosis factor α (TNF-α) monoclonal antibodies has provided...